A drug candidate design environment using evolutionary computation

IEEE Transactions on Evolutionary Computation

Volumn 12, Issue 5, 2008, Pages 591-603

  Ecemis, M Ihsan ^a   Wikel, James ^a   Bingham, Christopher ^a   Bonabeau, Eric ^b  

^a Coalesix Inc ^*  (United States)

^b ICOSYSTEM CORPORATION   (United States)

Author keywords

Computational chemistry; Drug design; Drug discovery; Genetic algorithms (GAs); In silico modeling; Interactive evolutionary computation; Lead optimization (LO); Virtual screening

Indexed keywords

COMPUTATIONAL CHEMISTRY; DRUG DESIGN; DRUG DISCOVERY; GENETIC ALGORITHMS (GAS); IN SILICO MODELING; INTERACTIVE EVOLUTIONARY COMPUTATION; LEAD OPTIMIZATION (LO); VIRTUAL SCREENING;

GENETIC ALGORITHMS;

EID: 53349167532     PISSN: 1089778X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TEVC.2007.913131     Document Type: Article

References (21)

1. J. A. DiMasi, R. W. Hansen, and H. G. Grabowski, "The price of innovation: New estimates of drug development costs," J. Health Econ., vol. 22, no. 2, pp. 151-185, 2003.
2. P. Landers, "Cost of developing a new drug increases to about $1.7 billion," The Wall Street Journal, Dec. 2003.
3. K. H. Bleicher, H.-J. Böhm, K. Müller, and A. I. Alanine, "Hit and lead generation: Beyond high-throughput screening," Nature Reviews Drug Discovery, vol. 2, no. 5, pp. 369-378, 2003.
4. E. Bonabeau, C. Anderson, B. Orme, P. Funes, O. Bandte, M. Sullivan, S. Malinchik, and J. Rothermich, "Methods and systems for interactive evolutionary computing (IEC)," U.S. 7043463, May 9, 2006.
5. J. H. Holland, Adaptation in Natural and Artificial Systems: An Introductory Analysis With Applications to Biology, Control and Artificial Intelligence. Cambridge, MA, USA: MIT Press, 1992.
6. D. B. Fogel, Evolutionary Computation: Toward a New Philosophy of Machine Intelligence. Piscataway, NJ: IEEE Press, 1995.
7. G. Jones, "Genetic and evolutionary algorithms," in Encyclopedia of Computational Chemistry, P. von Rague, Ed., Chichester, U.K., 1998.
8. G. Jones, P. Willett, and R. Glen, "Molecular recognition of receptor sites using a genetic algorithm with a description of desolation," J. Molecular Biol., vol. 245, pp. 43-53, 1995.
9. V. J. Gillet, W. Khatib, P. Willett, P. J. Fleming, and D. V. S. Green, "Combinatorial library design using a multiobjective genetic algorithm," J. Chem. Inf. Comput. Sci., vol. 42, no. 2, pp. 375-385, Mar.-Apr. 2002.
10. H. Takagi, "Interactive evolutionary computation: Fusion of the capabilities of EC optimization and human evaluation," Proc. IEEE vol. 89, pp. 1275-1296, 2001.
11. R. C. Glen and A. W. R. Payne, "A genetic algorithm for the automated generation of molecules within constraints," J. Computer-Aided Molecular Design, vol. 9, no. 2, pp. 181-202, 1995.
12. G. Schneider, M.-L. Lee, M. Stahl, and P. Schneider, "De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks," J. Computer-Aided Molecular Design, vol. 14, no. 5, pp. 487-494, 2000.
13. G. K.-M. Goh and J. A. Foster, "Evolving molecules for drug design using genetic algorithms via molecular trees," in Proc. GECCO, L. D. Whitley, D. E. Goldberg, E. Cantú-Paz, L. Spector, I. C. Parmee, and H. Beyer, Eds., 2000, pp. 27-33.
14. S. C.-H. Pegg, J. J. Haresco, and I. D. Kuntz, "A genetic algorithm for structure-based de novo design," J. Computer-Aided Molecular Design vol. 15, no. 10, pp. 911-933, 2001.
15. E.-W. Lameijer, J. N. Kok, T. Bäck, and A. P. IJzerman, "The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules," J. Chem. Inf. Model., vol. 46, no. 2, pp. 545-552, 2006.
16. F. Clerc, M. Lengliz, D. Farrusseng, C. Mirodatos, S. R. M. Pereira, and R. Rakotomalala, "Library design using genetic algorithms for catalyst discovery and optimization," Rev. Scientific Instrum., vol. 76, pp. 2208-2208, Jun. 2005.
17. S. R. M. Pereira, F. Clerc, D. Farrusseng, J. C. van der Waal, T. Maschmeyer, and C. Mirodatos, "Effect of the genetic algorithm parameters on the optimization of heterogeneous catalysts," QSAR Combinatorial Sci., vol. 24, no. 1, pp. 45-57, 2005.
18. B. V. Babu and R. Angira, "Modified differential evolution (MDE) for optimization of non-linear chemical processes," Comput. Chem. Eng. vol. 30, no. 6-7, pp. 989-1002, 2006.
19. B. V. Babu and R. Angira, "Optimization of process synthesis and design problems: A modified differential evolution approach," Chem. Eng. Sci., vol. 61, no. 14, pp. 4707-4721, 2006.
20. G. Klopman, S. Wang, M. R. Jacobs, S. Bajaksouzian, K. Edmonds, and J. J. Ellner, "Anti-mycobacterium avium activity of quinolones: In vitro activities," Antimicrobial Agents and Chemotherapy, vol. 37, no. 9, pp. 1799-1806, 1993.
21. G. Klopman, D. Fercu, T. E. Renau, and M. R. Jacobs, "N-1-tert-butyl-substituted quinolones: In vitro anti-mycobacterium avium activities and structure-activity relationship studies," Antimicrobial Agents and Chemotherapy, vol. 40, no. 11, pp. 2637-2643, 1996.